Microbot Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-11.44	-10.74	-13.17	-11.31	-9.17	Upgrade
Depreciation & Amortization	0.09	0.11	0.1	0.08	0.07	Upgrade
Loss (Gain) From Sale of Assets	-	0	0.01	-	-	Upgrade
Stock-Based Compensation	1.35	1.39	1.75	1.39	1.94	Upgrade
Other Operating Activities	-0	2.05	-0.01	-	-0.07	Upgrade
Change in Accounts Payable	0.87	-0.68	-0.24	0.32	-0.24	Upgrade
Change in Other Net Operating Assets	0.3	-0.66	0.01	0.18	0.22	Upgrade
Operating Cash Flow	-8.83	-8.53	-11.55	-9.35	-7.25	Upgrade
Capital Expenditures	-0.03	-0.03	-0.08	-0.07	-0.09	Upgrade
Investment in Securities	1.56	2.01	-3.75	3.27	-2.48	Upgrade
Investing Cash Flow	1.54	1.97	-3.84	3.2	-2.77	Upgrade
Issuance of Common Stock	7.94	6.56	4.32	-	-	Upgrade
Repurchase of Common Stock	-	-	-	-	-3.38	Upgrade
Financing Cash Flow	7.94	6.56	4.32	-	-3.38	Upgrade
Net Cash Flow	0.65	-0	-11.06	-6.15	-13.4	Upgrade
Free Cash Flow	-8.85	-8.57	-11.63	-9.42	-7.34	Upgrade
Free Cash Flow Per Share	-0.57	-0.84	-1.60	-1.33	-1.03	Upgrade
Cash Interest Paid	-	-	-	-	0.24	Upgrade
Levered Free Cash Flow	-5.87	-3.81	-6.67	-4.94	-3.3	Upgrade
Unlevered Free Cash Flow	-5.87	-3.81	-6.67	-4.94	-3.25	Upgrade
Change in Net Working Capital	0.02	-0.88	0.14	-0.77	-0.51	Upgrade

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q